Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
12.31
-0.37 (-2.88%)
At close: Jan 20, 2026, 4:00 PM EST
12.37
+0.06 (0.49%)
After-hours: Jan 20, 2026, 4:00 PM EST
COEP Revenue
Coeptis Therapeutics Holdings had revenue of $237.44K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $501.00K.
Revenue (ttm)
$501.00K
Revenue Growth
n/a
P/S Ratio
130.43
Revenue / Employee
$71,571
Employees
7
Market Cap
69.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 75.00K | 44.24K | 143.82% |
| Dec 31, 2020 | 30.76K | 6.67K | 27.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pelthos Therapeutics | 7.41M |
| Equillium | 4.39M |
| BeyondSpring | 1.88M |
| ImageneBio | 800.00K |
| aTyr Pharma | 190.00K |
| Entera Bio | 124.00K |
| InflaRx | 73.73K |
| Adlai Nortye | -1.35M |
COEP News
- 14 days ago - Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared - GlobeNewsWire
- 4 months ago - Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating - GlobeNewsWire
- 6 months ago - Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd - GlobeNewsWire
- 7 months ago - Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared - GlobeNewsWire
- 8 months ago - Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology - GlobeNewsWire
- 9 months ago - Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement - GlobeNewsWire
- 9 months ago - COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology - GlobeNewsWire
- 11 months ago - Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline - GlobeNewsWire